174 related articles for article (PubMed ID: 35053586)
1. cT1N0M0 Esophageal Squamous Cell Carcinoma Invades the Muscularis Mucosa or Submucosa: Comparison of the Results of Endoscopic Submucosal Dissection and Esophagectomy.
Wang CY; Chen BH; Lee CH; Le PH; Tsou YK; Lin CH
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053586
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic submucosal dissection
Qian M; Feng S; Zhou H; Chen L; Wang S; Zhang K
Therap Adv Gastroenterol; 2022; 15():17562848221138156. PubMed ID: 36458047
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant therapy for pT1a-m3/pT1b esophageal squamous cell carcinoma after endoscopic resection: Esophagectomy or chemoradiotherapy? A critical review.
Tsou YK; Lee CH; Le PH; Chen BH
Crit Rev Oncol Hematol; 2020 Mar; 147():102883. PubMed ID: 32014674
[TBL] [Abstract][Full Text] [Related]
4. Long-term clinical outcomes of patients diagnosed with pT1a-muscularis mucosae with lymphovascular invasion or pT1b after endoscopic resection for cT1N0M0 esophageal squamous cell carcinoma.
Kadota T; Sato D; Inaba A; Nishihara K; Takashima K; Nakajo K; Yukami H; Mishima S; Sawada K; Kotani D; Fujiwara H; Nakamura M; Hojo H; Yoda Y; Kojima T; Fujita T; Yano T
Esophagus; 2022 Jan; 19(1):153-162. PubMed ID: 34420139
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Benefit of Additional Treatment After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma.
Takahashi S; Hatta W; Watanabe K; Koike T; Shimada T; Hikichi T; Toya Y; Tanaka I; Onozato Y; Hamada K; Fukushi D; Watanabe K; Kayaba S; Ito H; Mikami T; Oikawa T; Takahashi Y; Kondo Y; Yoshimura T; Shiroki T; Nagino K; Hanabata N; Funakubo A; Hirasawa D; Ohira T; Nakamura J; Nakamura T; Nakaya N; Matsumoto T; Fukuda S; Masamune A; Iijima K
Dig Dis Sci; 2023 May; 68(5):2050-2060. PubMed ID: 36445654
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of esophageal squamous cell carcinoma with invasion depth of pathological T1a-muscularis mucosae and T1b-submucosa by endoscopic resection followed by appropriate additional treatment.
Naito S; Yoshio T; Ishiyama A; Tsuchida T; Tokura J; Namikawa K; Tokai Y; Yoshimizu S; Horiuchi Y; Hirasawa T; Asari T; Mine S; Watanabe M; Ogura M; Chin K; Fukuzawa M; Itoi T; Fujisaki J
Dig Endosc; 2022 May; 34(4):793-804. PubMed ID: 34599604
[TBL] [Abstract][Full Text] [Related]
7. Esophagectomy versus definitive chemoradiotherapy for patients with clinical stage N0 and pathological stage T1b esophageal squamous cell carcinoma after endoscopic submucosal dissection: study protocol for a multicenter randomized controlled trial (Ad-ESD Trial).
Yang Y; Su Y; Zhang X; Liu J; Zhang H; Li B; Hua R; Tan L; Chen H; Li Z
Trials; 2020 Jul; 21(1):603. PubMed ID: 32611448
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of Endoscopic Submucosal Dissection vs Esophagectomy for T1 Esophageal Squamous Cell Carcinoma in a Real-World Cohort.
Zhang Y; Ding H; Chen T; Zhang X; Chen WF; Li Q; Yao L; Korrapati P; Jin XJ; Zhang YX; Xu MD; Zhou PH
Clin Gastroenterol Hepatol; 2019 Jan; 17(1):73-81.e3. PubMed ID: 29704682
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic strategies following endoscopic submucosal dissection for T1a-MM/T1b-SM1 esophageal squamous cell carcinoma: comparisons of long-term outcomes with propensity score-matched analysis.
Li J; Wang L; Shi X; Chen J; Jin Z; Zou D; Li Z; Liu F
Surg Endosc; 2023 Mar; 37(3):1761-1770. PubMed ID: 36220991
[TBL] [Abstract][Full Text] [Related]
10. Combined assessment of clinical and pathological prognostic factors for deciding treatment strategies for esophageal squamous cell carcinoma invading into the muscularis mucosa or submucosa after endoscopic submucosal dissection.
Shimada T; Hatta W; Takahashi S; Koike T; Ohira T; Hikichi T; Toya Y; Tanaka I; Onozato Y; Hamada K; Fukushi D; Watanabe K; Kayaba S; Ito H; Mikami T; Oikawa T; Takahashi Y; Kondo Y; Yoshimura T; Shiroki T; Nagino K; Hanabata N; Funakubo A; Nakamura J; Matsumoto T; Iijima K; Fukuda S; Masamune A; Ito K;
Dig Endosc; 2022 Nov; 34(7):1382-1391. PubMed ID: 35702926
[TBL] [Abstract][Full Text] [Related]
11. Comparison of endoscopic submucosal dissection and surgery for superficial esophageal squamous cell carcinoma: a propensity score-matched analysis.
Min YW; Lee H; Song BG; Min BH; Kim HK; Choi YS; Lee JH; Hwang NY; Carriere KC; Rhee PL; Kim JJ; Zo JI; Shim YM
Gastrointest Endosc; 2018 Oct; 88(4):624-633. PubMed ID: 29750981
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic submucosal dissection versus esophagectomy for early esophageal squamous cell carcinoma with tumor invasion to different depths.
An W; Liu MY; Zhang J; Cui YP; Gao J; Wang LP; Chen Y; Yang LX; Chen HZ; Jin H; Liu F; Chen J; Li ZS; Wang LW; Shi XG; Sun C
Am J Cancer Res; 2020; 10(9):2977-2992. PubMed ID: 33042630
[TBL] [Abstract][Full Text] [Related]
13. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma.
Tanaka T; Ueno M; Iizuka T; Hoteya S; Haruta S; Udagawa H
Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30980070
[TBL] [Abstract][Full Text] [Related]
14. Additional radiotherapy following endoscopic submucosal dissection for T1a-MM/T1b-SM esophageal squamous cell carcinoma improves locoregional control.
Hisano O; Nonoshita T; Hirata H; Sasaki T; Watanabe H; Wakiyama H; Ono M; Ohga S; Honda H
Radiat Oncol; 2018 Jan; 13(1):14. PubMed ID: 29378603
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in clinical T1N0M0 thoracic esophageal squamous cell carcinoma invading the muscularis mucosa or submucosa.
Uchinami Y; Myojin M; Takahashi H; Harada K; Shimizu S; Hosokawa M
Radiat Oncol; 2016 Jun; 11():84. PubMed ID: 27328734
[TBL] [Abstract][Full Text] [Related]
16. Clinical Outcomes of Follow-Up Observation After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma Invading the Muscularis Mucosa Without Lymphovascular Involvement.
Iwai N; Dohi O; Yamada S; Ishida T; Fukui A; Horie R; Yasuda T; Yamada N; Horii Y; Majima A; Zen K; Yagi N; Naito Y; Itoh Y
Dig Dis Sci; 2023 Sep; 68(9):3679-3687. PubMed ID: 37470897
[TBL] [Abstract][Full Text] [Related]
17. Treatment Strategy after Endoscopic Resection of Superficial Esophageal Squamous Cell Carcinoma: A Single Institution Experience.
Lee HJ; Lee H; Park JC; Shin SK; Lee SK; Lee YC
Gut Liver; 2015 Nov; 9(6):714-9. PubMed ID: 25473076
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy and safety between endoscopic submucosal dissection, surgery and definitive chemoradiotherapy in patients with cT1N0M0 esophageal cancer.
Luo SA; Sun YY; Zeng YT; Huang CY
World J Gastrointest Endosc; 2024 Feb; 16(2):72-82. PubMed ID: 38464816
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer: choice of new approach.
Suzuki G; Yamazaki H; Aibe N; Masui K; Sasaki N; Shimizu D; Kimoto T; Shiozaki A; Dohi O; Fujiwara H; Ishikawa T; Konishi H; Naito Y; Otsuji E; Yamada K
Radiat Oncol; 2018 Dec; 13(1):246. PubMed ID: 30547811
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy comparison between surgical resection and endoscopic submucosal dissection of early gastric cancer in a domestic single center].
Rong L; Cai Y; Nian W; Wang X; Liang J; He Y; Zhang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):190-195. PubMed ID: 29492919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
